Literature DB >> 8112377

Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

K Kubota1, T Ishizaki.   

Abstract

Although sodium benzoate therapy is beneficial in patients with inborn error of urea cycle, it has been suggested that an accumulation of benzoyl-CoA would inhibit ureagenesis. In this study, we examined several aspects of ureagenesis after the single oral dosing of sodium benzoate in six healthy subjects who participated in the study previously reported and in two patients with citrullinaemia. Urea nitrogen appearance (UNA) did not change after the doses of 40, 80 and 160 mg.kg-1 of sodium benzoate in the 6 healthy subjects. Sum of UNA and urinary hippurate nitrogen (UHN) increased with increasing the dose. In the 2 patients with late-onset citrullinaemia who benefit from a partially functional urea cycle, no apparent inhibitory effects on the UNA were observed after the administration of 80 mg/kg of sodium benzoate. The precursors of urea (ammonia, glutamate, glutamine and alpha-amino nitrogen) did not increase after the benzoate administration in the 6 normal subjects as well as in the 2 patients with citrullinaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112377     DOI: 10.1007/bf00315519

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Evidence of inherited urea cycle defect in a case of fatal valproate toxicity.

Authors:  M Hjelm; L V de Silva; J W Seakins; V G Oberholzer; C J Rolles
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

2.  The effect of sodium benzoate on ammonia toxicity in rats.

Authors:  S M Maswoswe; D M Cyr; A D Griffith; G C Tremblay
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

3.  Determination of ammonia in blood plasma by an ion exchange method.

Authors:  K Kurahasi; A Ishihara; H Uehara
Journal:  Clin Chim Acta       Date:  1972-11       Impact factor: 3.786

4.  Nonlinear elimination of benzoate in patients with congenital hyperammonemia.

Authors:  K Oyanagi; Y Kuniya; A Tsuchiyama; T Nakao; E Owada; J Sato; K Ito
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

5.  Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.

Authors:  M L Batshaw; S W Brusilow
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

6.  A mechanism for valproate-induced hyperammonemia.

Authors:  F X Coude; D Rabier; L Cathelineau; G Grimber; P Parvy; P P Kamoun
Journal:  Pediatr Res       Date:  1981-06       Impact factor: 3.756

7.  Potentiation of hyperammonemia by sodium benzoate in animals. A note of caution.

Authors:  J E O'Connor; M Ribelles; S Grisolia
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

8.  Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.

Authors:  S W Brusilow; M Danney; L J Waber; M Batshaw; B Burton; L Levitsky; K Roth; C McKeethren; J Ward
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

9.  The effect of keto-analogues of essential amino acids in severe chronic uremia.

Authors:  M Walser; A W Coulter; S Dighe; F R Crantz
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

10.  New pathways of nitrogen excretion in inborn errors of urea synthesis.

Authors:  S W Brusilow; D L Valle; M Batshaw
Journal:  Lancet       Date:  1979-09-01       Impact factor: 79.321

View more
  1 in total

Review 1.  Alternative pathway therapy for urea cycle disorders.

Authors:  F Feillet; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.